Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Vivanza Biosciences Ltd

Thu 13/03/2025,0:0:0

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Director

    11 Mar 2025, 6:29PM Disclosure under Regulation 30 of SEBI (LODR) regarding intimation of Mr. Aagam Shah (DIN: 10602386), Independent Director of the Company.

  • Vivanza Biosciences - Integrated Filing (Financial)

    12 Feb 2025, 4:20PM INTEGRATED FILING- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2024.

  • Vivanza Biosciences - Outcome Of The Board Meeting.

    31 Jan 2025, 4:54PM Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. to consider and approve the Un-audited Financial Results for the Quarter and Nin

  • Vivanza Biosciences - Results For Quarter And Nine Months Ended 31St December, 2024

    31 Jan 2025, 4:41PM Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter

  • Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    30 Jan 2025, 6:19PM Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015.

  • Vivanza Biosciences - Board Meeting Intimation for Intimation Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listin

    24 Jan 2025, 3:40PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider

  • Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    16 Jan 2025, 6:50PM As of December 2024, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of

  • Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

    15 Jan 2025, 1:26PM Non-Applicability of Statement of Deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 7.9781 10.9623 5.5128 3.5404 3.4405
Liabilities 7.9781 10.9623 5.5128 3.5404 3.4405
Equity 4 4 4 4 4
Gross Profit 0.7998 0.7212 0.049 0.1259 -0.3021
Net Profit 0.3174 0.5691 0.4636 0.0998 -0.2037
Cash From Operating Activities 1.7835 0.1607 -0.6771 -3.0778 2.7961
NPM(%) 2.2 4 5.06 1.08 -2.16
Revenue 14.4132 14.2071 9.1475 9.2233 9.4289
Expenses 13.6134 13.4859 9.0984 9.0973 9.7311
ROE(%) 6.45 11.56 9.42 2.02 -4.14

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 1.23 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 4.47 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 9.28 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 4.22 -239.30 0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT